← Open Payments lookup

STEPHEN DIAMANTONI: Open Payments

NPI 1831240100 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,294 in 209 payments from 31 companies in 2025. Trend: 2023 $3,934 · 2024 $4,115 · 2025 $4,294

Food & beverage: $4,294
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP30$686
ABBVIE INC.32$602
Novo Nordisk Inc23$486
Lilly USA, LLC17$311
Supernus Pharmaceuticals, Inc.11$283
Bayer Healthcare Pharmaceuticals Inc.11$253
PFIZER INC.10$189
Astellas Pharma US Inc7$166
Boehringer Ingelheim Pharmaceuticals, Inc.9$155
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$152

Products named: AIRSUPRA, QULIPTA, Qelbree, Kerendia, JARDIANCE, Wegovy, MOUNJARO, Veozah.

Industry payments across PA — which companies pay providers there.